The next SUP meeting will take place in

Uppsala on the 26th of October.  The theme for the autum meeting is Infectious Diseases.


13.00-17.00 followed by mingle with light food


Elite Hotel Academia 


Justin Wilkins, Occams

PK/PD of the novel P. falciparum translation elongation factor 2 inhibitor cabamiquine.

Ayorinde Adehin, Mahidol Oxford Tropical Medicine Research Unit, Bangkok

Fexinidazole in Chagas disease: minimizing toxicity and optimizing efficacy.

TBC, Pharmetheus

Model-informed sustained release formulation development of 5-Flucytosine to treat cryptococcal meningitis.

Wendy Chu, Netherlands Cancer Institute & Uppsala University

Model-Based Characterization of the Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Burden in Post-Kala Azar Dermal Leishmaniasis Patients.

Yu-Jou Lin, Uppsala University

Multistate model of tuberculosis treatment outcomes and identification of predictors.

Lina Keutzer, Uppsala University

Linezolid, an old drug for new bugs - model-assisted optimization of linezolid dosing in resistant tuberculosis patients based on pharmacokinetics, efficacy and safety information.

Warm welcome!

Stockholm Uppsala Pharmacometrics (SUP)